Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 10, 2011, Pages 3078-3086

  Qiu, Zhong Ling ^a   Song, Hong Jun ^a   Xu, Yan Hong ^a   Luo, Quan Yong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; ANALGESIA; ARTICLE; BONE METASTASIS; BONE PAIN; BONE RADIOGRAPHY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DISTANT METASTASIS; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; ORTHOPEDIC SURGERY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SOLID TUMOR; SURVIVAL RATE; SURVIVAL TIME; THYROGLOBULIN BLOOD LEVEL; THYROID PAPILLARY CARCINOMA; TREATMENT RESPONSE;

ADENOCARCINOMA, PAPILLARY; ADULT; BONE NEOPLASMS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PAIN; PAIN MANAGEMENT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 80053463814     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0093     Document Type: Article

References (27)

1. Haigh PI, Urbach DR, Rotstein LE 2005 Extent of thyroidectomy is not a major determinant of survival in low or high-risk papillary thyroid cancer. Ann Surg Oncol 12:81-89 (Pubitemid 40486645)
2. Haq M, Harmer C 2005 Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol (Oxf) 63:87-93 (Pubitemid 40966408)
3. Qiu ZL, Luo QY 2009 Erector spinae metastases from differentiated thyroid cancer identified by I-131 SPECT/CT. Clin Nucl Med 34:137-140
4. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306 (Pubitemid 28065257)
5. 131I therapy on prognosis. J Nucl Med 49:1902-1903
6. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA 1988 Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 67:501-508
7. Marcocci C, Pacini F, Elisei R, Schipani E, Ceccarelli C, Miccoli P, Arganini M, Pinchera A 1989 Clinical and biologic behavior of bone metastases from differentiated thyroid carcinoma. Surgery 106:960-966 (Pubitemid 20012367)
8. Petrich T, Widjaja A, Musholt TJ, Hofmann M, Brunkhorst T, Ehrenheim C, Oetting G, Knapp WH 2001 Outcome after radioidine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age. Eur J Nucl Med 28:203-208
9. Seidlin SM, Marinelli LD, Oshry E 1946 Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid. J Am Med Assoc 132:838-847
10. McCormack KR 1966 Bone metastases from thyroid carcinoma. Cancer 19:181-184
11. Fanchiang JK, Lin JD, Huang MJ, Shih HN 1998 Papillary and follicular thyroid carcinomas with bone metastases: a series of 39 cases during a period of 18 years. Changgeng Yi Xue Za Zhi 21:377-382
12. Lin JD, Huang MJ, Juang JH, Chao TC, Huang BY, Chen KW, Chen JY, Li KL, Chen JF, Ho YS 1999 Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid 9:1227-1235
13. Orita Y, Sugitani I, Matsuura M, Ushijima M, Tsukahara K, Fujimoto Y, Kawabata K 2010 Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. Surgery 147:424-431
14. Pittas AG, Adler M, Fazzari M, Tickoo S, Rosai J, Larson SM, Robbins RJ 2000 Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid 10:261-268 (Pubitemid 30202413)
15. Pelikan DM, Lion HL, Hermans J, Goslings BM 1997 The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 47:713-720 (Pubitemid 28046560)
16. Proye CA, Dromer DH, Carnaille BM, Gontier AJ, Goropoulos A, Carpentier P, Lefebvre J, Decoulx M, Wemeau JL, Fossati P 1992 Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine? World J Surg 16:640-646
17. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schlumberger M 2006 Long term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioidine therapy. J Clin Endocrinol Metab 91:2892-2899 (Pubitemid 44271732)
18. Johnson NA, Tublin ME 2008 Postoperative surveillance of differentiated thyroid carcinoma: rationale, techniques, and controversies. Radiology 249:429-444
19. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C 1996 Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37:598-605 (Pubitemid 126618447)
20. Costelloe CM, Chuang HH, Madewell JE, Ueno NT 2010 Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST. J Cancer 1:80-92
21. Niederle B, Roka R, Schemper M, Fritsch A, Weissel M, Ramach W 1986 Surgical treatment of distant metastases in differentiated thyroid cancer: indication and results. Surgery 100:1088-1097 (Pubitemid 17223226)
22. Shaha AR, Loree TR, Shah JP 1995 Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118:1131-1138
23. Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME, Busnardo B 1993 Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 34:1626-1631 (Pubitemid 23295368)
24. Sciuto R, Romano L, Rea S, Marandino F, Sperduti I, Maini CL 2009 Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol 20:1728-1735
25. Heemstra KA, Liu YY, Stokkel M, Kievit J, Corssmit E, Pereira AM, Romijn JA, Smit JW 2007 Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 66:58-64 (Pubitemid 44952495)
26. Bernier MO, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F, Enkaoua E, Turpin G, Chiras J, Saillant G, Hejblum G 2001 Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 86:1568-1573 (Pubitemid 32374905)
27. Casara D, Rubello D, Saladini G, Gallo V, Masarotto G, Busnardo B 1991 Distant metastases in differentiated thyroid cancer: long-term results of radioiodine treatment and statistical analysis of prognostic factors in 214 patients. Tumori 77:432-436